Latest Director Remuneration News

Page 11 of 12
Invex Therapeutics reports a significant reduction in net loss for H1 FY2025 alongside promising pre-clinical data for Exenatide in Alzheimer’s Disease models.
Victor Sage
Victor Sage
7 Feb 2025
European Metals Holdings has made significant strides in developing its Cinovec Lithium Project, announcing a strategic relocation of its processing plant and ongoing enhancements to production capacity and cost efficiency. The Definitive Feasibility Study is on track for mid-2025 completion, promising a clearer outlook on the project's economic potential.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Toro Energy reports steady progress in its Wiluna Uranium Project with updated resource estimates and ongoing native title consultations, positioning itself to capitalize on improving uranium market conditions.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Somerset Minerals Ltd has taken a significant step forward by entering a conditional agreement to acquire the high-grade Coppermine Project in Nunavut, Canada, while completing the sale of its Valle del Tigre II mineral concession in Ecuador. Preparations are underway for a maiden exploration campaign at Coppermine, targeting substantial copper-silver mineralisation.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Bounty Oil and Gas NL reports steady cash reserves and rising oil production in Queensland, while facing regulatory setbacks offshore. The company’s strategic developments and entitlement offer position it for growth in 2025.
Victor Sage
Victor Sage
31 Jan 2025
Mustera Property Group progresses design and marketing for its McCabe Street development while maintaining sales momentum at Forbes Residences, alongside a notable executive remuneration update.
Eva Park
Eva Park
31 Jan 2025
Health and Plant Protein Group Limited reported a decline in cash reserves to $0.90 million for Q2 FY25, continuing its efforts to resolve a US tax withholding issue tied to a previous asset sale.
Eva Park
Eva Park
31 Jan 2025
Prescient Therapeutics has secured FDA clearance for its PTX-100 Phase 2 trial targeting relapsed/refractory cutaneous T-cell lymphoma, while also appointing James McDonnell as its new CEO. The company reports steady progress in its cell therapy platforms and maintains a solid cash position bolstered by a recent R&D tax rebate.
Ada Torres
Ada Torres
31 Jan 2025
Juno Minerals Limited reports steady progress on its Mount Mason hematite and Mount Ida lithium projects, securing government funding and revising logistics to streamline development. The company also raised $818,754 through a share placement, ending the quarter with $2.37 million in cash.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Northern Minerals Limited reported a $7.56 million net cash outflow from operating activities in the December 2024 quarter, offset by $28.5 million raised through borrowings, leaving a healthy cash balance of $35.76 million.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Comet Ridge has made significant strides in its Mahalo Gas Hub development, approving upstream FEED and progressing pipeline connections, supported by a strong cash position of $19.3 million. These developments position the company to address Australia's tightening east coast gas market.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Pancontinental Energy reports encouraging technical progress on its PEL 87 project with improved reservoir confidence and ongoing drilling success in Namibia’s Orange Basin, underpinning a solid cash position.
Maxwell Dee
Maxwell Dee
31 Jan 2025